SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-012322
Filing Date
2021-05-20
Accepted
2021-05-20 08:44:49
Documents
20
Period of Report
2021-05-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 43627
2 ex99-1.htm EX-99.1 16450
3 ex99-1_001.jpg GRAPHIC 73713
4 ex99-1_002.jpg GRAPHIC 212073
5 ex99-1_003.jpg GRAPHIC 182725
6 ex99-1_004.jpg GRAPHIC 92003
7 ex99-1_005.jpg GRAPHIC 80216
8 ex99-1_006.jpg GRAPHIC 109575
9 ex99-1_007.jpg GRAPHIC 67560
10 ex99-1_008.jpg GRAPHIC 106719
11 ex99-1_009.jpg GRAPHIC 86221
12 ex99-1_010.jpg GRAPHIC 72529
13 ex99-1_011.jpg GRAPHIC 172798
14 ex99-1_012.jpg GRAPHIC 83508
15 ex99-1_013.jpg GRAPHIC 92316
16 ex99-1_014.jpg GRAPHIC 98426
17 ex99-1_015.jpg GRAPHIC 93981
18 ex99-1_016.jpg GRAPHIC 75892
19 ex99-1_017.jpg GRAPHIC 104398
20 ex99-1_018.jpg GRAPHIC 89061
  Complete submission text file 0001493152-21-012322.txt   2670888
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 21942451
SIC: 2836 Biological Products, (No Diagnostic Substances)